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Abstract
Background: The way patients with coronary heart disease (CHD) are treated is partly determined by
non-medical factors. There is a solid body of evidence that patient and physician characteristics influence
doctors' management decisions. Relatively little is known about the role of structural issues in the decision
making process. This study focuses on the question whether doctors' diagnostic and therapeutic decisions
are influenced by the health care system in which they take place. This non-medical determinant of medical
decision-making was investigated in an international research project in the US, the UK and Germany.
Methods: Videotaped patients within an experimental study design were used. Experienced actors played
the role of patients with symptoms of CHD. Several alternative versions were taped featuring the same
script with patients of different sex, age and social status. The videotapes were shown to 384 randomly
selected primary care physicians in the three countries under study. The sample was stratified on gender
and duration of professional experience. Physicians were asked how they would diagnose and manage the
patient after watching the video vignette using a questionnaire with standardised and open-ended
questions.
Results: Results show only small differences in decision making between British and American physicians
in essential aspects of care. About 90% of the UK and US doctors identified CHD as one of the possible
diagnoses. Further similarities were found in test ordering and lifestyle advice. Some differences between
the US and UK were found in the certainty of the diagnoses, prescribed medications and referral
behaviour. There are numerous significant differences between Germany and the other two countries.
German physicians would ask fewer questions, they would order fewer tests, prescribe fewer medications
and give less lifestyle advice.
Conclusion: Although all physicians in the three countries under study were presented exactly the same
patient, some disparities in the diagnostic and patient management decisions were evident. Since other
possible influences on doctors treatment decisions are controlled within the experimental design,
characteristics of the health care system seem to be a crucial factor within the decision making process.
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There is an increasing interest in health care variations
between different national systems. Geographic variations
in health care depending on where the patient lives and
the system in which care is received have been shown in a
couple of studies, including studies dealing with the man-
agement of coronary heart disease (CHD) [1-5]. One pos-
sible explanation for such international variations in
health care lies in different systems of health care financ-
ing and reimbursement that may cause different priorities
in patient management [6]. According to the 'supplier-
induced demand' thesis [7-9] physicians have the ability
to generate demand and thus, differences in financial
incentives for providing services could lead to variations
in health care in different countries. Evidence-based med-
icine has emerged as an international health care para-
digm which promotes the use of tools like disease
management programs and clinical guidelines, to influ-
ence provider decision making, improve the quality of
care and reduce both national and eventually interna-
tional variations [5]. However, while disease management
programs for CHD patients are well established in the US
and the UK, countries like Germany have just recently
started to build such managed care structures.
Against this background comparative findings from an
international research project on clinical decision making
in patients with symptoms of CHD are presented in this
paper. We have chosen three countries, each with a differ-
ent organisation and financing of health care (a largely
private insurance-based health care system in the US, a
National Health Service government-supported, tax-based
system in the UK, and a system characterized by decentral-
ized care administered by social security agencies in Ger-
many). The aim of the study was to simultaneously
measure the effect of country/the health care system,
patient attributes, and physician characteristics on dispar-
ities in clinical decision making of primary care providers.




A factorial experiment with a videotaped patient consulta-
tion was conducted [10-14]. Due to the experimental
approach relevant patient (age, gender, social status, race)
and physician factors (experience, gender) are controlled
by the study design. Professional actors played the role of
patients with symptoms of CHD. Patients in the video-
vignette presented several symptoms that are typical for
CHD including chest pressure; pressure worsened with
exertion, stress and eating; relief after resting; discomfort
for more than three months; pain through the back
between the shoulder blades; and elevated blood pres-
sure. Additionally a non-verbal cue was incorporated,
demonstrated by the 'Levine fist' (clenched fist to the ster-
num) [15,16]. Tape-recorded role-playing sessions were
conducted with experienced clinical advisors. From these
tapes one script was developed that was used for all vide-
otapes presented to physicians with appropriate language
(British English vs. American English) modifications. The
portrayed patients in the US had American accents, while
the very same in the UK had English accents. For the Ger-
man part of the study the US-videotapes were dubbed by
a professional speaker. To this end, scripts were translated
into German and then back into English to identify dis-
crepancies between original and back-translation. This
forward-backward process was repeated until satisfactory
agreement was attained. To ensure clinical accuracy and
comparability with the other two countries the speaker
was asked to adhere to the translated script, instead of giv-
ing priority to synchrony. Moreover, care was taken to
construct a culturally neutral medical practice setting for
the filming. The patient in the videotapes was portrayed as
having consulted this doctor before and having recently
returned from vacation/holiday. The videos were pre-
sented to primary care physicians in their own practice
rooms. Actors on the tapes differ according to their age
(55 vs. 75 years), gender (male vs. female) and social sta-
tus (low vs. high depicted by their current/former occupa-
tion of a janitor/cleaner or school teacher) in order to
mirror respective patient characteristics. In addition race
(black vs. white) was varied in the US and the UK. As black
patients in Germany are very rare, this characteristic was
not varied in the videos in Germany. One CHD-video was
presented to each physician. After viewing the tapes the
physicians were asked a range of questions concerning
patient management by using a questionnaire with both
standardised and open-ended questions. The physicians
were asked what questions they would ask, to name the
most likely diagnoses, what their certainty levels were,
which test(s) they would order, which medication(s) they
would prescribe, and what lifestyle recommendation(s)
they would make if they saw the patient from the video in
their everyday clinical practice. In terms of information
seeking behaviour, the question was whether the physi-
cians would ask the patient any additional questions (yes/
no) and if so, what kind of question(s) they would ask
(open ended). In terms of diagnostic decision making,
doctors were asked what they thought was going on with
the patient (open ended) and how certain they were with
their diagnostic decision (from 0 to 100). Moreover, phy-
sicians were asked whether they would order any tests for
this patient (yes/no) and to name the tests they would
order (open ended). In terms of therapy, we wanted to
know if doctors would prescribe or recommend any med-
ication (yes/no), if they would refer the patient to another
health care professional (yes/no) and when they would
like to see the patient again (in days). Finally, physicians
were asked if they would recommend any lifestyle advicePage 2 of 7
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advice they would give (open ended).
Physician sample
The study was conducted in the US (Massachusetts), in the
UK (the West Midlands, Southeast London and Surrey)
and in Germany (North Rhine-Westphalia). Physicians
were randomly selected from lists provided by local
health care organizations. Selection was made within four
strata, defined by combinations of the physicians' gender
and length of clinical experience. In order to get a clear
separation by level of experience only physicians with less
than 5 years or more than 15 years clinical experience
were considered eligible for selection. Moreover, physi-
cians had to be internists or family practitioners in the US
and in Germany or general practitioners in the UK. For a
clear separation by country they had to be trained at a
medical school in their respective countries. Altogether
384 interviews were conducted in the three countries (128
in each country). For a sample size of 384 physicians the
design has 80% power to detect absolute differences of
14.5 percent between two groups. For example, if 14.5%
of physicians would refer a patient to a cardiologist/spe-
cialist facility in one country and 29% of physicians
would refer a patient to a cardiologist/specialist facility in
another (a difference of 14.5%) then we would expect to
find a significant difference (at alpha = 0.05) 80 percent of
the time. Randomly selected physicians were sent a letter
of invitation. Thereafter, these physicians were screened
over the phone so that eligible doctors could be identified.
An appointment was scheduled for the personal one hour
semi-structured interview in the physicians practice. Data
were collected in 2001/2002 in UK and the US, and in
2004/2005 in Germany. Participating doctors received a
modest financial acknowledgement. The response rates
were 64.9% in the US, 59.6% in the UK, and 65% in Ger-
many. Informed consent was signed by all participating
physicians. This consent form was approved as required
by the US Institutional Review Board and conformed to
requirements of UK and German ethics committees. The
overall study was approved by the New England Research
Institutes Institutional Review Board.
External validity
Since videotaped patients were used, physicians may
behave differently under experimental conditions com-
pared with real patients in their everyday clinical work. To
address this issue several steps were taken to foster the
external validity of the study design. High effort was
devoted to increase the clinical realism of the vignettes.
Due to the conducted role-play sessions, the scripts are
based on clinical experience. At the filming, experienced
clinicians were present on the set and only professional
actors were engaged. At the beginning of each interview
during the fieldwork doctors were specifically asked how
typical the patient on the videotape was, compared to
patients they encounter in everyday practice. 90.6% con-
sidered them either very typical or reasonably typical in
the US, 91.4% in the UK and 81.3% in Germany. Addi-
tionally, all physicians viewed the tapes in the context of
their own practice during normal practice hours so that it
was likely they encountered real patients before and after
they participated in the study. Prior to the interview, all
physicians were instructed to view the patient as one of
their own patients, and to respond as they would typically
respond in their own practice.
Statistical methods
Analysis of variance was used to assess the country effect
on doctors' diagnostic and therapeutic decisions. Given
the balanced factorial design, the main effect due to coun-
try is orthogonal to (independent of) the main effects due
to physicians and patients factors. Tukey's studentized
range multiple comparisons were performed to test statis-
tical significance of differences between the three coun-
tries. Precise p-values are reported in the tables. P < 0.05
was considered to be an indication that the differences
noted were statistically significant.
Results
Information seeking behaviour
Table 1 summarizes major differences between randomly
sampled physicians in the US, the UK and in Germany in
their information seeking behaviour. After the physicians
saw the videotaped patient we wanted to know if they
would ask the patient any additional questions. The aver-
age total number of questions is highest in the US (8.7),
followed by the UK (5.5) and Germany (3.1). Several sig-
nificant differences regarding topics raised also exist
between the three countries under study. 83% of the US
physicians would like to know more about the medical
history, more than in the UK (62%) and in Germany
(39%). Questioning related to pain differs significantly
between Germany (32%) and the other two countries (US
62%, UK 57%). All three countries differ significantly
with respect to questions referring to the patient's general
health status (US 83% vs. UK 62% vs. Germany 30%). In
terms of questions about smoking and alcohol consump-
tion, US and UK physicians do not differ significantly,
however in Germany, physicians' question behaviour is
significantly different. Only 20% of the German GPs
would ask about smoking (vs. US 57% and UK 48%) and
only 8% would ask about alcohol consumption (vs. US
34% and UK 31%).
Diagnosis
Although all physicians in the three countries encoun-
tered exactly the same patient on the videotape, there are
country differences in the percentage of medical practi-
tioners who mentioned coronary heart disease as a possi-Page 3 of 7
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the UK and 74% of the German physicians mentioned
CHD when they were asked what they think is going on
with the patient. Only Germany significantly differs from
the other countries in this regard. After mentioning CHD
as a possible diagnosis, physicians were asked how certain
on a scale from 0 to 100 they are with their diagnosis (for
physicians who did not give a CHD diagnosis, their cer-
tainty was set to 0). The level of certainty significantly dif-
fers between the US (58%) and the two other countries
(UK 46% and Germany 39%). There is no significant dif-
ference in the percentage of general practitioners who
would order a test to diagnose a possible CHD between
the US (89%) and the UK (80%), but again Germany
(39%) differs significantly from the other countries. Tak-
ing a look at the total number of tests that were ordered to
detect CHD, the same results can be found. Germany sig-
nificantly differs (0.9 tests) from the US (3.2 tests) and the
UK (3.5 tests).
Therapy
Results on therapy decisions are presented in Table 3. The
prescribing behaviour differs significantly in all three
countries. 67% of the US general practitioners would pre-
scribe or recommend a medication before having the
results of any test ordered. In the UK 48% would do the
same, whilst in Germany only 17% of the physicians
would prescribe a drug. In terms of referrals to a cardiolo-
gist there are significant differences between the UK
(31%) and the other two countries. Referral to another
medical specialist significantly differs amongst all coun-
tries (US 5% vs. UK 30% vs. Germany 52%). Although the
time to the next appointment does not significantly vary
between the US (11.3 days) and the UK (13.1 days), Ger-
man physicians would like to see the patient again signif-
icantly sooner (5.7 days).
Lifestyle advice
The physicians were asked whether they would give any
lifestyle advice. General practitioners in the US (2.8
pieces) and the UK (2.9 pieces) do not differ in the aver-
age number of pieces of advice, but the German GPs
would give significantly less advice (1.9 pieces) (Table 4).
Country differences can additionally be found by the kind
of advice that was given. Large and significant differences
are evident for the recommendation to stop smoking (US
32% vs. UK 55% vs. Germany 9%). The suggestion to
reduce alcohol consumption was given by 18% of the
physicians in the US and 36% in the UK. Only 10% of the
German GPs would raise this topic, but the difference to
Table 1: Total numbers of additional questions and percentages of physicians who would ask the patient different types of additional 
questions by country
Countries
p country Germany UK US Tukey's Multiple Comparison
Number of questions (means) < .0001 3.1 5.5 8.7 US > UK > Germany
Questions about (%)
pathology .3879 69 77 71 UK = US = Germany
medical history < .0001 39 62 83 US > UK > Germany
pain < .0001 32 57 62 US = UK > Germany
smoking < .0001 20 48 57 US = UK > Germany
alcohol < .0001 8 31 34 US = UK > Germany
psychological state .0226 20 33 35 US = UK > Germany
social .0901 17 14 25 US = Germany = UK
general < .0001 30 62 83 US > UK > Germany
Table 2: Coronary heart disease (CHD) diagnosis, certainty of diagnosis and test ordering for CHD by country
Countries
p country Germany UK US Tukey's Multiple Comparison
CHD diagnosis (%) < .0001 74 88 95 US = UK > Germany
Certainty of CHD diagnosis (0–100) < .0001 39 46 58 US > UK = Germany
Test for CHD (%) < .0001 39 80 89 US = UK > Germany
Number of tests for CHD (means) < .0001 0.9 3.5 3.2 UK = US > GermanyPage 4 of 7
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non-significant differences in the advice for weight reduc-
tion, exercise and diet were found.
Discussion
This paper focuses on between-country differences in clin-
ical decision making in CHD. Doctors' diagnostic and
management decisions were compared in three countries
(US, UK and Germany) with different health insurance
systems. To analyse the country effect on doctors' deci-
sions a factorial experiment with video vignettes was con-
ducted. Working with vignettes is a sophisticated and
valid method for measuring the quality of care provided
by primary care physicians [17]. This design was success-
fully used in previous studies to estimate the un-con-
founded effects of non-medical factors in clinical decision
making [10,18,19]. While this rigorous experimental
study permits excellent internal validity, external validity
remains a threat. Substantial effort was devoted to pro-
duce the video vignettes to be as realistic as possible.
However, patient management decisions result from the
interaction between physician and patient and from clin-
ical examination. These issues could not be adequately
addressed in a videotape-based experiment. Furthermore,
doctors may have viewed the interview as a test situation.
This could possibly bias the answers in the direction of
social acceptability. To avoid this, the doctors were specif-
ically told that the interview is not a test, and that we are
interested in their daily work and not in textbook answers.
While there are some methodological limitations, the
design has considerable strengths. The factorial experi-
ment allows the estimation of independent and un-con-
founded country effects as it simultaneously controls for
different types of patient (age, gender, social status, and
race) and provider influences (gender and length of clini-
cal experience) on clinical decision making. Although
there are more physician and patient characteristics, these
are considered important for the decision making process.
In addition, the experimental approach with videotaped
patients offers the possibility to integrate non-verbal signs
such as the 'Levine fist'. To enhance generalizability doc-
tors were randomly selected.
Even though all patients reported exactly the same symp-
toms, results indicate differences between countries, espe-
cially between Germany on the one hand and the US and
the UK on the other. Minor non-consistent differences
were found in patient management between British and
American physicians (see also [5]): British doctors gave
lifestyle recommendations regarding alcohol and smok-
ing more often and referred their patients to a cardiologist
or other medical specialist more frequently. American
doctors were more certain about a CHD diagnosis, they
would request more additional information from the
patient, and they provided more prescriptions appropri-
ate to CHD. Physicians in Germany showed a significantly
different pattern of behaviour. They asked fewer addi-
tional questions, diagnosed CHD less often, and were also
Table 3: Therapy decisions by country
Countries
p country Germany UK US Tukey's Multiple Comparison
Prescribing appropriate CHD medication (%) < .0001 17 48 67 US > UK > Germany
Referral to a cardiologist or specialist facility (%) < .0001 19 31 10 UK > Germany = US
Referral to other medical professional (%) < .0001 52 30 5 Germany > UK > US
Time to next appointment (days, means)) < .0001 5.7 13.1 11.3 UK = US > Germany
Table 4: Total Numbers and percentages of physicians who give different types of lifestyle advice and recommendations by country
Countries
p country Germany UK US Tukey's Multiple Comparison
Total numbers of advice (means) < .0001 1.9 2.9 2.8 UK = US > Germany
Advice about (%)
diet .7507 51 53 55 US = UK = Germany
smoking < .0001 9 55 32 UK > US > Germany
alcohol < .0001 10 36 18 UK > US = Germany
relaxation .1873 9 11 5 UK = Germany = US
exercise .7643 7 9 6 UK = Germany = US
weight .0824 3 8 2 UK = Germany = USPage 5 of 7
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doctors. Among German physicians, a minor proportion
would order a CHD specific test and if so, they would
order fewer tests. Medications were prescribed to a lesser
extent, but patients would see the doctor again sooner.
Finally the total number of pieces of lifestyle advice given
to the patient and the kind of advice significantly differs
from the UK and US. Overall, German physicians would
be less active in terms of diagnostic and management
strategies. The reasons for this discrepancy may be struc-
tural.
In our study physicians were asked how much time they
do have for a patient consultation (e.g., for a routine
patient consultation, American physicians are allocated
on average 18 minutes, British physicians are allocated 10
minutes, and German physicians are allocated 5.5 min-
utes). Generally, German physicians have the least time
for patient consultations compared with UK and espe-
cially with US doctors. At the same time, German physi-
cians would like to see the patient again much sooner.
Thus, physicians in Germany seem to have the smallest
time allocation for a single consultation while they would
see the patients in smaller intervals. These different time
restrictions might cause varying treatment strategies. Fur-
thermore, there is a relationship between organizational
structure and clinical performance [20]. Differing struc-
tures of health care financing and reimbursement are
likely to influence clinical decision making. Thus, charac-
teristics of the health care system in each country might be
one explanation for the observed country differences.
Although we consider these structural reasons most
important, other explanations can't be ruled out. First,
there might be cultural reasons for our results indicating
that German physicians are less active in terms of diagnos-
tic and management strategies than their US and UK col-
leagues. For example, physicians' behaviour may reflect
different patient expectations. Secondly, there are possible
methodological reasons for the different physicians'
behaviour in Germany, as data were collected 3 years later
than in the other two countries and vignettes in Germany
were dubbed. The slightly different way that the videotape
was made may have altered physicians' perception of the
patient in Germany. However, more than 80% of the Ger-
man physicians considered the patient on the videotape
either very typical or reasonably typical compared to
patients they encounter in everyday practice (in the UK
and the US this rate was about 90%).
Conclusion
Results indicate country differences in clinical decision
making related to CHD, especially between Germany on
the one hand and the US and the UK on the other. Partic-
ularly structures of health care financing and the state of
evidence-based care programs can explain the observed
country differences. In this regard, incentives for different
diagnostic and therapeutic procedures can be seen as pre-
dictors of clinical decisions.
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